Cargando…

Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women

OBJECTIVE: The purpose of this study was to clarify the clinical features of epithelial ovarian carcinoma (EOC) in younger vs. older patients in Japan. METHODS: We collected data on 1,562 patients with EOC treated at multiple institutions in the Tokai Ovarian Tumor Study Group, and analyzed them ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshikawa, Nobuhisa, Kajiyama, Hiroaki, Mizuno, Mika, Shibata, Kiyosumi, Kawai, Michiyasu, Nagasaka, Tetsuro, Kikkawa, Fumitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996261/ https://www.ncbi.nlm.nih.gov/pubmed/24761215 http://dx.doi.org/10.3802/jgo.2014.25.2.118

Ejemplares similares

Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

Epidemiological overview of metastatic ovarian carcinoma: long-term experience of TOTSG database
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

The possible existence of occult metastasis in patients with ovarian clear-cell carcinoma who underwent complete resection without any residual tumours
por: Kajiyama, Hiroaki, et al.
Publicado: (2018)

Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology
por: Kajiyama, Hiroaki, et al.
Publicado: (2014)

The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma
por: Kajiyama, Hiroaki, et al.
Publicado: (2020)

Estrogen producing ovarian fibrosarcoma: A case report
por: Miura, Mayo, et al.
Publicado: (2019)

Fertility-sparing surgery of malignant transformation arising from mature cystic teratoma of the ovary
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2018)

Growing Teratoma Syndrome of the Ovary Showing Three Patterns of Metastasis: A Case Report
por: Shibata, Kiyosumi, et al.
Publicado: (2013)

Comparison of prognoses according to non‐positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.
por: Maeda, Osamu, et al.
Publicado: (2016)

PRIMA-1(MET) induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells
por: YOSHIKAWA, NOBUHISA, et al.
Publicado: (2016)

The Therapeutic Effects of Goreisan, a Traditional Japanese Herbal Medicine, on Lower-Limb Lymphedema after Lymphadenectomy in Gynecologic Malignancies: A Case Series Study
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
por: Terauchi, Mikio, et al.
Publicado: (2007)

Preclinical Verification of the Efficacy and Safety of Aqueous Plasma for Ovarian Cancer Therapy
por: Nakamura, Kae, et al.
Publicado: (2021)

Fertility-Sparing surgery for young women with ovarian endometrioid carcinoma: a multicenteric comparative study using inverse probability of treatment weighting
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear-cell carcinoma cells
por: Kawai, Yosuke, et al.
Publicado: (2018)

HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells
por: Yuan, Hong, et al.
Publicado: (2015)

Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma
por: Suzuki, Shiro, et al.
Publicado: (2016)

Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients
por: Mizuno, M, et al.
Publicado: (2015)

Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
por: Ukai, Mayu, et al.
Publicado: (2021)

Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma
por: Yoshida, Kosuke, et al.
Publicado: (2019)

Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer
por: Tsukamoto, Hirohisa, et al.
Publicado: (2008)

Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells
por: Sakata, Jun, et al.
Publicado: (2017)

Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: Two case reports
por: Suzuki, Shiro, et al.
Publicado: (2014)

Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells
por: Koya, Yoshihiro, et al.
Publicado: (2018)

GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth
por: LUO, CHENHONG, et al.
Publicado: (2014)

P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling
por: Shibata, Kiyosumi, et al.
Publicado: (2007)

UNEXPECTED OVARIAN MALIGNANCY FOUND AFTER LAPAROSCOPIC SURGERY IN PATIENTS WITH ADNEXAL MASSES –A SINGLE INSTITUTIONAL EXPERIENCE–
por: SAITO, SHIGEKO, et al.
Publicado: (2014)

Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma
por: Shimbo, Akiko, et al.
Publicado: (2019)

Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery
por: Kajiyama, H, et al.
Publicado: (2011)

The Preoperative Prognostic Nutritional Index for the Prediction of Outcomes in Patients with Early-Stage Ovarian Clear Cell Carcinoma
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy
por: Nakao, Yuri, et al.
Publicado: (2020)

The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study
por: Adachi, Manabu, et al.
Publicado: (2015)

Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
por: Niimi, Kaoru, et al.
Publicado: (2014)

Variable susceptibility of ovarian cancer cells to non-thermal plasma-activated medium
por: UTSUMI, FUMI, et al.
Publicado: (2016)

Plasma-activated medium promotes autophagic cell death along with alteration of the mTOR pathway
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

Establishment and characterization of cell lines derived from complete hydatidiform mole
por: Yamamoto, Eiko, et al.
Publicado: (2017)

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012)

Ovarian cancer‐associated mesothelial cells induce acquired platinum‐resistance in peritoneal metastasis via the FN1/Akt signaling pathway
por: Yoshihara, Masato, et al.
Publicado: (2020)

Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
por: Nakamura, Kae, et al.
Publicado: (2017)

Selective cytotoxicity of indirect nonequilibrium atmospheric pressure plasma against ovarian clear-cell carcinoma
por: Utsumi, Fumi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_75s77mvjvtjjnn1ajrm6qee3et